Cargando…

The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review

Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization...

Descripción completa

Detalles Bibliográficos
Autores principales: Glenn, Tanya L., Kotlyar, Alex M., Seifer, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231975/
https://www.ncbi.nlm.nih.gov/pubmed/34198564
http://dx.doi.org/10.3390/jcm10122616
_version_ 1783713539253338112
author Glenn, Tanya L.
Kotlyar, Alex M.
Seifer, David B.
author_facet Glenn, Tanya L.
Kotlyar, Alex M.
Seifer, David B.
author_sort Glenn, Tanya L.
collection PubMed
description Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization rate, total fertilization failure, and live birth rate per cycle (LBR), comparing the use of ICSI versus conventional in vitro fertilization (IVF) for non-male factor infertility. The overwhelming conclusion shows no increase in fertilization rate or LBR per cycle with the use of ICSI for non-male factor infertility. The overuse of ICSI is likely related to the desire to avoid a higher rate of total fertilization failure in IVF. However, data supporting the benefit of using ICSI for non-male factor infertility is lacking, and 33 couples would need to be treated with ICSI unnecessarily to avoid one case of total fertilization failure. Such practice increases the cost to the patient, increases the burden on embryologist’s time, and is a misapplication of resources. Additionally, there remains conflicting data regarding the safety of offspring conceived by ICSI and potential damage to the oocyte. Thus, the use of ICSI should be limited to those with male factor infertility or a history of total fertilization factor infertility due to uncertainties of potential adverse impact and lack of proven benefit in non-male factor infertility.
format Online
Article
Text
id pubmed-8231975
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82319752021-06-26 The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review Glenn, Tanya L. Kotlyar, Alex M. Seifer, David B. J Clin Med Review Intracytoplasmic sperm injection (ICSI) was originally designed to overcome barriers due to male factor infertility. However, a surveillance study found that ICSI use in non-male factor infertility increased from 15.4% to 66.9% between 1996 and 2012. Numerous studies have investigated fertilization rate, total fertilization failure, and live birth rate per cycle (LBR), comparing the use of ICSI versus conventional in vitro fertilization (IVF) for non-male factor infertility. The overwhelming conclusion shows no increase in fertilization rate or LBR per cycle with the use of ICSI for non-male factor infertility. The overuse of ICSI is likely related to the desire to avoid a higher rate of total fertilization failure in IVF. However, data supporting the benefit of using ICSI for non-male factor infertility is lacking, and 33 couples would need to be treated with ICSI unnecessarily to avoid one case of total fertilization failure. Such practice increases the cost to the patient, increases the burden on embryologist’s time, and is a misapplication of resources. Additionally, there remains conflicting data regarding the safety of offspring conceived by ICSI and potential damage to the oocyte. Thus, the use of ICSI should be limited to those with male factor infertility or a history of total fertilization factor infertility due to uncertainties of potential adverse impact and lack of proven benefit in non-male factor infertility. MDPI 2021-06-14 /pmc/articles/PMC8231975/ /pubmed/34198564 http://dx.doi.org/10.3390/jcm10122616 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Glenn, Tanya L.
Kotlyar, Alex M.
Seifer, David B.
The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title_full The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title_fullStr The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title_full_unstemmed The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title_short The Impact of Intracytoplasmic Sperm Injection in Non-Male Factor Infertility—A Critical Review
title_sort impact of intracytoplasmic sperm injection in non-male factor infertility—a critical review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231975/
https://www.ncbi.nlm.nih.gov/pubmed/34198564
http://dx.doi.org/10.3390/jcm10122616
work_keys_str_mv AT glenntanyal theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview
AT kotlyaralexm theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview
AT seiferdavidb theimpactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview
AT glenntanyal impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview
AT kotlyaralexm impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview
AT seiferdavidb impactofintracytoplasmicsperminjectioninnonmalefactorinfertilityacriticalreview